Annual Cash & Cash Equivalents
$56.86 M
-$10.35 M-15.40%
December 31, 2023
Summary
- As of February 10, 2025, ZBIO annual cash & cash equivalents is $56.86 million, with the most recent change of -$10.35 million (-15.40%) on December 31, 2023.
- During the last 3 years, ZBIO annual cash & cash equivalents has fallen by -$10.35 million (-15.40%).
- ZBIO annual cash & cash equivalents is now -15.40% below its all-time high of $67.21 million, reached on December 31, 2022.
Performance
ZBIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$360.04 M
+$176.11 M+95.75%
September 30, 2024
Summary
- As of February 10, 2025, ZBIO quarterly cash and cash equivalents is $360.04 million, with the most recent change of +$176.11 million (+95.75%) on September 30, 2024.
- Over the past year, ZBIO quarterly cash and cash equivalents has increased by +$322.88 million (+869.04%).
- ZBIO quarterly cash and cash equivalents is now at all-time high.
Performance
ZBIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ZBIO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.4% | +869.0% |
| 3 y3 years | -15.4% | +869.0% |
| 5 y5 years | -15.4% | +869.0% |
ZBIO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.4% | at low | at high | +869.0% |
| 5 y | 5-year | -15.4% | at low | at high | +869.0% |
| alltime | all time | -15.4% | at low | at high | +869.0% |
Zenas BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $360.04 M(+95.7%) |
| Jun 2024 | - | $183.93 M(+395.0%) |
| Mar 2024 | - | $37.15 M(-34.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $56.86 M(-15.4%) | $56.86 M(-21.4%) |
| Sep 2023 | - | $72.31 M |
| Dec 2022 | $67.21 M | - |
FAQ
- What is Zenas BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Zenas BioPharma?
- What is Zenas BioPharma annual cash & cash equivalents year-on-year change?
- What is Zenas BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Zenas BioPharma?
- What is Zenas BioPharma quarterly cash and cash equivalents year-on-year change?
What is Zenas BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of ZBIO is $56.86 M
What is the all time high annual cash & cash equivalents for Zenas BioPharma?
Zenas BioPharma all-time high annual cash & cash equivalents is $67.21 M
What is Zenas BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, ZBIO annual cash & cash equivalents has changed by -$10.35 M (-15.40%)
What is Zenas BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ZBIO is $360.04 M
What is the all time high quarterly cash and cash equivalents for Zenas BioPharma?
Zenas BioPharma all-time high quarterly cash and cash equivalents is $360.04 M
What is Zenas BioPharma quarterly cash and cash equivalents year-on-year change?
Over the past year, ZBIO quarterly cash and cash equivalents has changed by +$322.88 M (+869.04%)